The Briefing RoomApril 13, 2026via Financial Times Technology
AI chatbots misdiagnose in over 80% of early medical cases, study finds
Why it matters
A peer-reviewed study on AI safety and reliability in high-stakes medical domains exposes a critical governance gap: major LLM providers haven't adequately validated their models for clinical use. This is the kind of regulatory/ethics story that will shape enterprise AI procurement and liability frameworks.
Key signals
- Over 80% misdiagnosis rate in early medical cases
- Models tested: OpenAI and DeepSeek flagged for rapid judgments on incomplete data
- Issue: LLMs making clinical decisions without sufficient guardrails or validation
- Published by Financial Times (credible source)
- Implications for healthcare AI deployment and liability
The hook
80%+ misdiagnosis rate. AI chatbots are rushing to judgment on incomplete patient data—and healthcare leaders need to know before deployment.
Top models including OpenAI and DeepSeek make judgments too quickly when patient data is incomplete
Relevance score:78/100